Virtus LifeSci Biotech Clinical Trials ETF Rating $21.01 -0.01 (-0.05%) As of 01:36 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatingsShort InterestBuy This Stock Virtus LifeSci Biotech Clinical Trials ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBC Aggregate RatingModerate Buy 2.88Holdings in BBC have an aggregate rating of Moderate Buy based on 197 analyst ratings issued in the past year covering 24 companies (26.0% of the portfolio).BBC Aggregate Price Target$21.010.00% DownsideHigh Prediction$21.01Average Prediction$21.01Low Prediction$21.01Holdings in BBC have an aggregate price target of $21.01 and a range of $21.01 to $21.01 covering 24 companies (26.0% of the portfolio).BBC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy14 Buy rating(s)Moderate Buy7 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Clinical Trials ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 BBC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.51%SANASana Biotechnology$3.16+6.2%3.307 of 5 stars3.00$9.17 190.5%7News CoverageUpcoming EarningsGap Up1.38%VERVVerve Therapeutics$11.133.388 of 5 stars2.33$14.57 30.9%9Upcoming Earnings1.36%COGTCogent Biosciences$10.84-0.2%3.0627 of 5 stars2.82$18.70 72.6%11Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision1.27%NTLAIntellia Therapeutics$10.68-6.8%4.608 of 5 stars2.65$32.84 207.5%20News CoverageEarnings ReportUpcoming EarningsAnalyst Forecast1.23%ABCLAbCellera Biologics$4.23-0.4%3.2575 of 5 stars3.00$8.00 89.3%6News CoverageEarnings ReportAnalyst ForecastGap Up1.20%TERNTerns Pharmaceuticals$6.10+8.2%4.057 of 5 stars2.60$15.63 156.1%5Earnings ReportAnalyst Revision1.07%RAPPRapport Therapeutics$14.86-3.6%1.8102 of 5 stars3.00$29.50 98.6%2News CoverageEarnings ReportUpcoming EarningsAnalyst ForecastAnalyst Revision1.06%PHVSPharvaris$20.18-0.7%1.7093 of 5 stars3.00$36.20 79.4%5Upcoming Earnings1.06%CNTACentessa Pharmaceuticals$17.01-1.0%3.0749 of 5 stars3.00$28.10 65.2%11Upcoming Earnings1.04%MNMDMind Medicine (MindMed)$9.81-1.9%2.0649 of 5 stars3.22$24.71 152.1%9Trending NewsAnalyst RevisionGap Up1.04%SMMTSummit Therapeutics$28.66+2.1%2.0294 of 5 stars2.79$34.67 21.0%14Positive NewsOptions Volume1.04%TNGXTango Therapeutics$6.50-1.7%1.9442 of 5 stars3.00$10.33 59.0%4News CoverageEarnings ReportAnalyst ForecastAnalyst Revision1.02%NUVBNuvation Bio$2.36+0.6%2.0244 of 5 stars3.20$7.17 204.3%5News CoverageEarnings Report1.02%GHRSGH Research$12.42+2.6%2.7592 of 5 stars3.00$32.00 157.8%7Positive NewsEarnings Report1.01%PRTAProthena$7.83+1.4%2.9382 of 5 stars2.33$30.25 286.6%9Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision1.00%RXRXRecursion Pharmaceuticals$5.39-0.4%1.8745 of 5 stars2.33$7.00 29.9%6Earnings ReportAnalyst Revision0.98%MAZEMaze Therapeutics$13.24-0.6%N/A3.29$25.60 93.4%7News CoveragePositive News0.97%BEAMBeam Therapeutics$17.54-1.8%2.7533 of 5 stars3.07$48.45 176.2%14Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision0.97%PRAXPraxis Precision Medicines$45.89-2.9%1.6465 of 5 stars2.78$95.22 107.5%9Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision0.96%AUTLAutolus Therapeutics$2.33-1.1%2.7448 of 5 stars3.00$9.32 300.9%5Upcoming EarningsGap Up0.96%MLTXMoonLake Immunotherapeutics$51.94+0.1%2.4826 of 5 stars2.78$74.43 43.3%9News CoveragePositive NewsEarnings ReportAnalyst ForecastAnalyst Revision0.95%KALVKalVista Pharmaceuticals$12.660.0%3.787 of 5 stars3.11$26.29 107.7%90.94%SRRKScholar Rock$32.20+2.6%4.4709 of 5 stars3.22$45.14 40.2%9News CoverageEarnings ReportAnalyst Forecast0.94%RNACCartesian Therapeutics$10.31-2.2%2.122 of 5 stars2.80$40.00 288.2%5News CoveragePositive News This page (NYSEARCA:BBC) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredGold Hit $3,500. Here’s What’s Next…Gold just smashed through $3,500—and some experts believe that’s only the beginning. With big banks like Goldm...Reagan Gold Group | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Clinical Trials ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Clinical Trials ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
